Journal Article

Are the effects of statins on HDL-cholesterol clinically relevant?

M.J. Chapman

in European Heart Journal Supplements

Published on behalf of European Society of Cardiology

Volume 6, issue suppl_C, pages C58-C63
Published in print July 2004 | ISSN: 1520-765X
Published online July 2004 | e-ISSN: 1554-2815 | DOI:
Are the effects of statins on HDL-cholesterol clinically relevant?

Show Summary Details


It has been established that the level of plasma high-density lipoprotein (HDL)-cholesterol is inversely proportional to the risk of coronary heart disease (CHD). HDL particles are highly heterogeneous, particularly in terms of their biological activities, many of which are atheroprotective. For example, in addition to carrying out reverse cholesterol transport, HDL protects the vascular endothelium by inhibiting monocyte adhesion and the oxidative modification of low-density lipoprotein (LDL), eliminates some of the atherogenic products of LDL oxidation, and possesses antithrombotic activity, due to the inhibition of platelet activation and aggregation. Statin therapy has been shown to increase the level of plasma HDL-cholesterol. However, the clinical benefit of statin-induced elevation of HDL-cholesterol is unclear from trial data, perhaps as a result of the concomitant overwhelming risk benefit of statin-induced reduction of LDL-cholesterol.

Keywords: Atheroprotection; High-density lipoprotein; Low-density lipoprotein; Statin therapy

Journal Article.  3673 words.  Illustrated.

Subjects: Cardiovascular Medicine

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.